A leading inhalation expert

Iconovo is a Swedish CDMO company, offering innovative inhalation platforms to the international pharmaceutical industry. We have several types of patented dry powder inhaler devices, and inhouse formulation, for the development of complete inhalation products within both new pharmaceuticals and generic medicine. As a leading inhaler expert, Iconovo is the knowledgeable partner you need to accelerate opportunities and time to market.

Latest news from Iconovo

About Q2-2024 report by CEO Johan Wäborg at Carnegie

Iconovo released the Q2-2024 report today and the CEO at Iconovo, Johan Wäborg was invited to the Carnegie Bank studio to comment and give some more flavor…

Iconovo releases Q2-2024 report

“A quarter of intense business development and constructive negotiations." says Johan Wäborg, CEO at Iconovo. CEO MESSAGES:  STRATEGIC INITIATIVES…

Dr Orest Lastow presenting Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies

Iconovo to present at New Updates in Drug Formulation & Bioavailability in Copenhagen August 28th. Dr Orest Lastow, CTO at Iconovo will present on…

Meet us


New Updates in Drug Formulation & Bioavailability

August 28, 2024


NLS Days 

September 17-19, 2024



October 8-10, 2024


MVIC Inhalation Symposium 

October 16-17, 2024



Redeye Investor Forum Online 

August 29th or September 19th

Redeye Investor Forum Göteborg

October 10th

Redeye Medtech & Diagnostics 

November 13th

Redeye Life Science Day 

December 3rd

Carnegie Bolagsdag

December 5th

We are a specialized CDMO that develops inhalation products in our patented, innovative inhalers, supporting customers in bringing their inhaled treatments to market.

Learn more


Four differentiated technical platforms

We develop inhaled medicines from your drug substance as your complete inhalation partner. We take you all the way through your pharmaceutical product development, from idea to finalized inhalation product. Our strength is the integrated development of inhaler and dry powder formulation. Four differentiated technical inhaler platforms can be optimized with your unique dry powder formulation, and we also assist with manufacturing of clinical trial material in early clinical trials and technical documentation for registrations.

Learn more


Engineering and pharmaceutical expertise

Iconovo has an integrated development process, with all competences and facilities inhouse. With a unique combination of engineering and pharmaceutical expertise, our capabilities include devices, formulation, pharmaceutical analysis, and advisory services.

Learn more

Stay up to date with Iconovo’s news and press releases